🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/06/2004 | 12,09 | 12,21 | 11,84 | 11,92 | -0,87% | 3,06% | 307.600 |
| 03/06/2004 | 12,00 | 12,18 | 11,83 | 12,03 | -0,66% | 2,92% | 482.400 |
| 02/06/2004 | 12,11 | 12,25 | 12,00 | 12,11 | -0,41% | 2,11% | 325.400 |
| 01/06/2004 | 11,91 | 12,23 | 11,82 | 12,16 | +2,75% | 3,48% | 733.600 |
| 28/05/2004 | 11,87 | 11,87 | 11,71 | 11,83 | -0,88% | 1,39% | 399.800 |
| 27/05/2004 | 12,06 | 12,12 | 11,63 | 11,94 | -0,79% | 4,10% | 388.000 |
| 26/05/2004 | 11,70 | 12,07 | 11,67 | 12,03 | +2,95% | 3,42% | 965.600 |
| 25/05/2004 | 11,62 | 11,76 | 11,50 | 11,69 | +0,21% | 2,24% | 1.290.600 |
| 24/05/2004 | 12,20 | 12,44 | 11,62 | 11,66 | -2,67% | 6,72% | 958.800 |
| 21/05/2004 | 11,84 | 12,10 | 11,80 | 11,98 | +1,83% | 2,53% | 1.111.000 |
| 20/05/2004 | 11,57 | 12,00 | 11,27 | 11,77 | +2,35% | 6,31% | 817.600 |
| 19/05/2004 | 11,83 | 12,19 | 11,45 | 11,50 | -3,28% | 6,26% | 577.800 |
| 18/05/2004 | 11,70 | 11,90 | 11,54 | 11,89 | +1,97% | 3,04% | 291.000 |
| 17/05/2004 | 11,81 | 11,90 | 11,63 | 11,66 | -1,81% | 2,29% | 411.800 |
| 14/05/2004 | 11,92 | 12,13 | 11,77 | 11,87 | -1,04% | 2,98% | 204.400 |
| 13/05/2004 | 12,11 | 12,26 | 11,93 | 12,00 | -0,54% | 2,73% | 389.600 |
| 12/05/2004 | 12,17 | 12,22 | 11,67 | 12,06 | -1,07% | 4,56% | 621.800 |
| 11/05/2004 | 11,91 | 12,30 | 11,91 | 12,19 | +2,31% | 3,23% | 919.400 |
| 10/05/2004 | 12,37 | 12,37 | 11,79 | 11,92 | -2,66% | 4,73% | 1.022.000 |
| 07/05/2004 | 12,35 | 12,51 | 12,14 | 12,24 | -2,08% | 2,96% | 2.463.000 |
| 06/05/2004 | 12,63 | 12,75 | 12,29 | 12,50 | -3,59% | 3,64% | 2.227.000 |
| 05/05/2004 | 12,80 | 13,03 | 12,63 | 12,97 | +1,85% | 3,13% | 772.200 |
| 04/05/2004 | 12,76 | 12,87 | 12,66 | 12,73 | -0,59% | 1,68% | 1.628.800 |
| 03/05/2004 | 12,31 | 12,98 | 12,22 | 12,81 | +4,02% | 6,13% | 1.318.000 |
| 30/04/2004 | 12,63 | 12,73 | 12,22 | 12,31 | -1,99% | 4,08% | 790.800 |
| 29/04/2004 | 12,62 | 12,79 | 12,45 | 12,56 | -0,12% | 2,65% | 379.200 |
| 28/04/2004 | 12,90 | 12,90 | 12,52 | 12,58 | -2,41% | 2,95% | 867.200 |
| 27/04/2004 | 12,22 | 13,34 | 12,15 | 12,89 | +5,61% | 9,78% | 2.149.800 |
| 26/04/2004 | 11,90 | 12,30 | 11,86 | 12,20 | +2,78% | 3,66% | 923.600 |
| 23/04/2004 | 11,71 | 11,89 | 11,52 | 11,87 | +1,63% | 3,20% | 622.400 |